Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Eli Lilly and Co reaffirms FY 2014 outlook


Thursday, 24 Jul 2014 06:31am EDT 

Eli Lilly and Co:Expects FY 2014 earnings per share to be in the range of $2.67 to $2.75 on a reported basis.On a non-GAAP basis, it still expects FY 2014 earnings per share to be in the range of $2.72 to $2.80.Continues to expects FY 2014 revenue of between $19.4 - $20.0 bln.Continues to expects FY 2014 net income to be at least $2.9 bln.FY 2014 EPS of $2.78, revenue of $19.9 bln, net income of $2.9 bln - Thomson Reuters I/B/E/S. 

Latest Key Developments in Pharmaceuticals

Company Quote

71.12
0.95 +1.35%
2 Mar 2015